The medication has undergone extensive clinical evaluation through the SUSTAIN trials for diabetes and STEP trials for weight management, establishing both efficacy and safety across diverse patient populations
doi: 10.1016/0031-9384(86)90115-0 145 McLaughlinCLBaileCA
It is manufactured using cGMP processes and the ALLMAX 5-Stage Quality Guarantee ensures ultimate purity, quality, and effectiveness
Frequently used noninvasive measures (Supplementary Table 1) include biometric markers (body weight, body mass index, and hepatic fat), liver function markers (alanine aminotransferase, aspartate aminotransferase, and gamma-glutamyl transferase), lipid markers (plasma cholesterol, triacylglycerol, high-density lipid cholesterol, and low-density lipid cholesterol), glycemic markers (fasting plasma glucose, insulin, homeostatic model assessment for insulin resistance and glycated hemoglobin)
The Pediatric Neurology Advisory Committee in 1996 and some textbooks and manuals strongly recommended carnitine supplementation (50100 mg/kg per day) during VPA therapy for children at risk for developing a carnitine deficiency, in VPA overdose and in VHT [33, 92, 93]
It plays a significant role in tissue remodeling, wound healing, and skin regeneration